AI assistant
Genus PLC Director's Dealing 2025
4873_dirs_2025-02-28_7a1304c8-b46c-45bc-820b-ba1549cde955.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information 
RNS Number : 9334Y
Genus PLC
28 February 2025
28 February 2025
Genus plc
Director/PDMR Shareholding
Genus plc (LSE: GNS) announces that further to the vesting on 28 February 2025 of 44,933 nil-cost options granted on 2 May 2023 over ordinary shares pursuant to Listing Rule 9.4.2R , as listed in table A below, Jorgen Kokke, Chief Executive Officer, sold 19,967 ordinary shares in Genus on 28 February 2025 on the London Stock Exchange to offset income tax and social security liabilities due on the exercise of those vested options and retained the balance of 24,966 ordinary shares.
The below notifications, made in accordance with Article 19 of the Market Abuse Regulation (EU) 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, give further detail on the number of nil-cost options exercised and ordinary shares sold on 28 February 2025.
For further information please contact:
Genus:
Cara Guedeney, Deputy Company Secretary Tel: +44 (0)1256 347100
Table A - Exercise of buy-out awards vesting on 28 February 2025
1.
Details of the person discharging managerial responsibilities / person closely associated
a.
Name
Jorgen Kokke
2.
Reason for the notification
a.
Position/status
Chief Executive
b.
Initial notification
/Amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.
Name
Genus plc
b.
LEI
54930022EOITNKSIGH56
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.
Description of the
Financial instrument, type of instrument
Identification code
Ordinary shares of 10p each
GB0002074580
b.
Nature of the transaction
Exercise of nil-cost options granted on 2 May 2023 under Listing Rule 9.4.2R over ordinary shares in Genus.
c.
Price(s) and volume(s)
| Price | Volume |
| 0p | 44,933 |
d.
Aggregated information
· Aggregated volume
· Price
| Price(s) | Volume(s) |
| 0p | 44,933 |
e.
Date of the transaction
2025-02-28
f.
Place of the transaction
Outside a trading venue.
5.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.
Description of the
Financial instrument, type of instrument
Identification code
Ordinary shares of 10p each
GB0002074580
b.
Nature of the transaction
Sale of shares arising from the exercise of nil-cost options under Listing Rule 9.4.2R to offset income tax and social security liabilities due on the exercise.
c.
Price(s) and volume(s)
| Price | Volume |
| 1,730.51p | 19,967 |
d.
Aggregated information
· Aggregated volume
· Price
| Price | Volume |
| 1,730.51p | 19,967 |
e.
Date of the transaction
2025-02-28
f.
Place of the transaction
London Stock Exchange, Main Market (XLON)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHUWUORVBUUUAR